Diaceutics PLC

DXRX.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£2£1-£3-£0
Dep. & Amort.£3£2£2£2
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£1£0£0
Change in WC£4-£6£3-£1
Other Non-Cash-£4£2-£1-£0
Operating Cash Flow£1-£1£2£1
Investing Activities
PP&E Inv.-£0-£0-£1-£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.-£3-£3£0-£1
Investing Cash Flow-£3-£3-£1-£2
Financing Activities
Debt Repay.-£0£0-£0£0
Stock Issued£0£0£0£0
Stock Repurch.£0£0£0-£0
Dividends Paid£0£0£0£0
Other Fin. Act.£0-£0£0-£0
Financing Cash Flow-£0-£0£0-£0
Forex Effect-£0-£0-£0-£0
Net Chg. in Cash-£2-£4£0-£1
Supplemental Information
Beg. Cash£13£17£17£18
End Cash£10£13£17£17
Free Cash Flow£1-£1£1£1
Diaceutics PLC (DXRX.L) Financial Statements & Key Stats | AlphaPilot